Regulators from across the globe emphasized that the realization of the “Smokefree 2030” policy requires the introduction of rational e-cigarette regulation policies through collaboration between the tobacco industry, regulators, and policymakers.The 13th Global Tobacco & Nicotine Forum 2023 (GTNF 2
As the number of people with musculoskeletal disorders increases due to the growing older adult population, interest is mounting in home rehabilitation exercises that allow people to continue their rehabilitation at home.Rehabilitation exercises can prevent recurrence after surgery and help patients
Patient groups and the Ministry of Food and Drug Safety are running parallel over the safety and efficacy of generic drugs for Parkinson's.Industry insiders are watching how the dispute continues amid mounting patient dissatisfaction with generic drugs.The bickering began in December 2021 when globa
Biogen, maker of the spinal muscular atrophy (SMA) drug Spinraza (nusinersen), and Roche, maker of Evrysdi (risdiplam), recently reached a dramatic agreement with the government by even extending drug price negotiations.Now, the patients are also shifting their attention to dosing standardsAccording
Kakao Healthcare and i-SENS said they have signed a contract to cooperate in the supply of continuous glucose monitoring (CGM) devices and data linkage-based blood glucose management services.The two companies have been discussing cooperation since July last year and had signed a memorandum of under
Alteogen, a company specializing in next-generation biobetters, said on Tuesday that it obtained a U.S. patent regarding its proprietary antibody technology.In particular, the patent covers the technology of the antibody which specifically bind to the folate receptor alpha (FOLR1). The patent was gr
In a strategic move to strengthen its global position, SK pharmteco announced its acquisition of the US-based cell and gene therapy (CGT) contract development and manufacturing organization (CDMO), The Center for Breakthrough Medicines (CBM).With this acquisition, SK pharmteco plans to emerge as a l
Multinational medical device companies are gearing up to showcase their latest breakthroughs and innovations at the much-anticipated Korea Clinical Radiology (KCR) 2023 convention.The convention will be held from Wednesday to Friday at COEX, Seoul.Philips Korea plans to present its new ways to manag
Novartis Korea said it held the seventh emotional support program, CHEERYOU, for patients with rare and intractable diseases in collaboration with the Korean Organization for Rare Diseases (KORD) at the Pine Valley Glamping Site in Pocheon, Gyeonggi Province, last Friday.The CHEERYOU campaign, a fla
Osteoporotic fractures continue to rise due to rapid population aging. By 2025, the number of hip and spine fractures due to osteoporosis is expected to increase by 140 percent. Osteoporotic fractures, typically associated with osteoporosis, are a common geriatric condition.Osteoporosis is a conditi
ST Pharm said it has taken its first step towards becoming the global leader in the oligonucleotide contract development and manufacturing organization (CDMO) domain with the groundbreaking ceremony for its second oligonucleotide facility on Monday.The new plant will be located in Ansan, Gyeonggi Pr
As Korean and foreign pharmaceutical and biotechnology companies are stepping up to develop antibody-drug conjugates (ADCs), Daiichi Sankyo presented its outlook on the future direction of ADC development.Daiichi Sankyo co-developed Enhertu (trastuzumab deruxtecan), a new generation ADC anticancer d
About 8,000 doctors prescribed medical narcotics to themselves annually for the past three years, prompting calls for banning doctors from self-prescribing narcotic drugs by law.These and other facts were revealed at a public debate organized by Rep. Choi Youn-suk of the ruling People Power Party (P
U.S. biopharmaceutical company Rani Therapeutics has embarked on a phase 1 clinical trial of oral ustekinumab (RT-111) using Celltrion's Stellara biosimilar CT-P43.In January, Celltrion agreed with Rani to develop oral ustekinumab and adalimumab (Humira). Celltrion will develop its antibodies as ora
Severance Hospital’s Yonsei Cancer Center announced the promising results of heavy ion therapy performed on a patient diagnosed with stage 2 prostate cancer, marking a significant milestone in the nation's medical field.Heavy ion therapy involves accelerating heavy carbon ions to 70 percent of the s
Coreline Soft's shares plummeted on its first trading day on the tech-heavy Kosdaq market on Monday.As of market close Monday, the company's shares stood at 35,000 won ($26.39), down 25.05 percent from its initial public offering price at 46,000 won. According to an analyst, the drop in shares is pr
GE HealthCare Korea showcased its advanced obstetric diagnostic ultrasound technology, including its 3D ultrasound, during the BeFE Baby Fair 2023 held at COEX, Seoul, from Sep. 14 to 17.The event served as a platform to educate visitors about the benefits of 3D ultrasound, which has become essentia
PharmAbcine received approval from the Australian Human Research Ethics Committees (HRECs) last Friday to conduct a phase 1a/b clinical trial of PMC-309.PMC-309 is a VISTA-targeted immuno-oncology agent for patients with advanced or metastatic solid tumors.According to PharmAbcine, PMC-309 is an IgG
HLB said Monday that its U.S. subsidiary, Elevar Therapeutics, will attend the European Society for Medical Oncology (ESMO) 2023 in Madrid from Oct. 20 to 24 to discuss partnerships with leading European pharmaceutical companies for the distribution and sale of rivoceranib in Europe.Eleva will run a
As the number of shingles vaccinations among older adults has steadily increased, the government must work out measures, including free vaccinations for the elderly and vulnerable people, a lawmaker said Monday.Rep. In Jae-geun of the Democratic Party of Korea made these and other points based on an